accelerating covid-19 drug discovery: qualified assays for proinflammatory cytokines
Published 3 years ago • 250 plays • Length 42:13Download video MP4
Download video MP3
Similar videos
-
24:50
covid-19 drug discovery with qualified cell-based assays for proinflammatory cytokines
-
22:49
eurofins discovery pegs conference 2021 therapeutic interventions for covid-19
-
30:23
accelerating immuno-oncology drug discovery with moa-reflective, functional cell-based assays
-
4:15
how ai is accelerating drug discovery
-
40:10
discovery of bacterial effectors in the human microbiome and isolation of a gpcr g2agpr132 agonist
-
3:31
insilico medicine's first ai-discovered antifibrotic drug goes first-in-human
-
12:58
eurofins discoverx internalization assays
-
1:05:12
eurofins discovery services
-
52:45
global anticancer drug discovery & development trends
-
23:09
eurofins discoverx custom capabilites
-
55:18
eurofins integrated drug discovery webinar
-
2:02
eurofins discovery: it all starts with biology
-
2:01
eurofins discovery: we know what it takes
-
16:16
key factors to accelerate drug discovery
-
57:59
accelerating drug discovery to fight covid with ai
-
2:58
pharmacology discovery services - capabilities video
-
23:07
eurofins discovery biomarker services
-
2:39:58
accelerating the process from basic drug discovery to clinical trial for covid-19 - scilifelab
-
17:46
recent trends in kinase drug discovery